FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 319:683-688 September 15, 1988 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Bulimia nervosa is a prevalent disorder of unknown cause, characterized by recurrent episodes of uncontrollable eating. In the light of recent evidence that the gastrointestinal hormone cholecystokinin induces satiety and reduces food intake in laboratory animals and humans, we investigated the hypothesis that abnormalities in cholecystokinin secretion and satiety may occur in patients with bulimia and contribute to their disturbed eating patterns. Blood levels of cholecystokinin and subjective satiety were measured in 14 women with bulimia and 10 normal women before and after a mixed-liquid meal. The total integrated plasma cholecystokinin response to eating was significantly impaired in patients with bulimia (P less than 0.05) as was postprandial satiety. Fasting cholecystokinin levels were similar in both populations (approximately 0.8 pmol per liter). After eating, however, mean (+/- SEM) peak plasma cholecystokinin levels increased to 4.1 +/- 0.9 pmol per liter in normal controls but to only 2.1 +/- 0.2 pmol per liter in patients with bulimia nervosa (P less than 0.05). After an open trial of tricyclic antidepressants in a subgroup of five patients with bulimia, the postprandial cholecystokinin response to eating increased significantly, to 6.6 +/- 1.2 pmol per liter (P less than 0.05), and there was an increase in the satiety response. We conclude that patients with bulimia do not have normal satiety and have impaired secretion of cholecystokinin in response to a meal. Preliminary evidence suggests that both these abnormalities may be improved by treatment with tricyclic antidepressants.

Source Information

Clinical Neuroendocrinology Branch, National Institute of Mental Health, Bethesda, Md.

This article has been cited by other articles:

• Geliebter, A., Ochner, C. N., Aviram-Friedman, R. (2008). Appetite-Related Gut Peptides in Obesity and Binge Eating Disorder. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2: 305-314 [Abstract]  
• Hannon-Engel, S. L. (2008). Knowledge Development: The Roy Adaptation Model and Bulimia Nervosa. Nurs Sci Q 21: 126-132 [Abstract]  
• Keel, P. K., Wolfe, B. E., Liddle, R. A., De Young, K. P., Jimerson, D. C. (2007). Clinical Features and Physiological Response to a Test Meal in Purging Disorder and Bulimia Nervosa. Arch Gen Psychiatry 64: 1058-1066 [Abstract] [Full Text]  
• (2007). References. APPI Online CME 2007: 2-2 [Full Text]  
• Aja, S. (2006). Serotonin-3 receptors in gastric mechanisms of cholecystokinin-induced satiety. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291: R112-R114 [Full Text]  
• Sysko, R., Walsh, B T., Schebendach, J., Wilson, G T. (2005). Eating behavior among women with anorexia nervosa. Am. J. Clin. Nutr. 82: 296-301 [Abstract] [Full Text]  
• Date, Y., Toshinai, K., Koda, S., Miyazato, M., Shimbara, T., Tsuruta, T., Niijima, A., Kangawa, K., Nakazato, M. (2005). Peripheral Interaction of Ghrelin with Cholecystokinin on Feeding Regulation. Endocrinology 146: 3518-3525 [Abstract] [Full Text]  
• Burton-Freeman, B. (2005). Sex and Cognitive Dietary Restraint Influence Cholecystokinin Release and Satiety in Response to Preloads Varying in Fatty Acid Composition and Content. J. Nutr. 135: 1407-1414 [Abstract] [Full Text]  
• Geliebter, A., Gluck, M. E., Hashim, S. A. (2005). Plasma Ghrelin Concentrations Are Lower in Binge-Eating Disorder. J. Nutr. 135: 1326-1330 [Abstract] [Full Text]  
• (1988). BULIMIA AND IMPAIRED CHOLECYSTOKININ RELEASE. JWatch General 1988: 5-5 [Full Text]